Roy Exum: My Pimples And Andrea Sloan

Monday, September 30, 2013 - by Roy Exum
Roy Exum
Roy Exum

A real long time ago I was having a fit with acne. I was a lovelorn teenager, infatuated with pretty girls in a dizzy game where pimples can really become cumbersome. It seemed like nothing was working and, after I grew a pimple large enough for its own zip code, I finally found a genius doctor who quickly became my lifelong hero when he came up with a marvelous idea.

At the time there was a new “super drug”  that was languishing through years of “clinical trials” in the United States and nobody could get any, despite the fact the revolutionary medicine was already available in Germany. My hero called up a close friend who was a German doctor and – presto! – the first 250 pills came flying across the ocean.

I had to promise that I would not sue anybody if I grew an extra set of ears, developed female breasts, or my eyes turned yellow, but, honestly, I would have dyed my hair green to get the American-made medicine. After I took a course of what was then identified by only a strange laboratory number, my pimples and my acne were gone forever. I had Clark Gable looks and never looked back. That’s a true story (except the Gable part.)

Other fellow Americans had to wait for many months. I don’t believe that's right. Since this occurred in my formative years, I have cursed the federal Food and Drug Administration for much of my adult life because the “clinical trials” process we use is horribly dysfunctional and in critical need of an overhaul.

To illustrate my point, allow me to introduce a beautiful Texas lawyer, Andrea Sloan. Yes, she is quite pretty but “beautiful” because her career has been as the executive director of a Texas advocacy project that provides free legal services to low-income victims of domestic or sexual abuse.

Andrea is a victim herself, not just of stage 3c ovarian cancer but a horribly-tangled FDA system. Her doctors have exhausted every known method to save her life. Six years of surgery, radiation, and chemotherapy haven’t worked. She’s still very much a patient at the world-famous M.D. Anderson Medical Center and her oncologist believes an experimental drug called “BMN 673” might well save Andrea’s life.

M.D. Anderson has a good supply of BMN 673 on hand but with millions of dollars at stake, the manufacturer, BioMarin in California, has said no. “It would be unethical and reckless to provide end-stage refractory ovarian cancer patients outside clinical trial with BMN 673 at this early stage of development,” said spokesperson Debra Charlesworth.

“If we did,” Charlesworth explained to CNN, “we would be exposing the experimental drug to a large group without adequate testing. There have been previous circumstances where early access to large groups has resulted in adverse consequences that were worse than the course of the disease.”

I am certain no scientist can hardly wait for somebody to try to explain to me what “adverse consequences” could possibly be worse than what Andrea Sloan is facing without BMN 673. Andrea is pleading for the drug – let the petals of the flower fall where they may – and probably understands the risks as much as anyone involved. She knows what will happen if she fails to get BMN 673 better than anyone else, too.

Here is what she wrote in a statement to the drug company: “I recognize the importance of weighing the risk and the myriad of considerations they face as a company. However, this is a risk worth taking. I will thank them. My family will thank them. An amazing army of loyal supporters, to whom I owe a debt of gratitude, will thank them. In America we do not leave our wounded warriors on the battleground. BioMarin, please be the Calvary that saves me.”

Her M.D. Anderson doctors believe Andrea is a great candidate. Further, the FDA itself has just announced Ms. Sloan qualifies for a “compassionate care” waiver in the rules but the manufacturer, BioMarin, still says no. The word is BioMarin stands to make about $500 million on the drug and, even though they say they plan to give away 10 percent of the medicine to charity, they refuse to face the ethical dilemma.

As of Sunday afternoon Andrea had almost 170,000 supporters on her Change.org webpage and politician Newt Gingrich, co-host of CNN’s “Crossfire” program, is irate at “a corporation protecting its wallet at the expense on Andrea’s possibly dying. If you want to know why big companies often get bad names, it’s explaining that clerical support to fill out FDA paperwork is too difficult when you can save a life.”

Dr. Charles Levenback, Andrea’s doctor, is disappointed at BioMarin’s stance but, as a man who sees the fight against cancer every day, he told CNN reporters, “My own belief is that the drug companies, the manufacturers, the insurance companies, the providers like my hospital M.D. Anderson, the individual medical professionals, the investigators, the patients -- everybody wants the same things. Safe, effect, novel therapies for as many people as it's appropriate for. Even BioMarin, I believe. I don't think this is like 'Let the masses eat cake.' I think they're on the same mission. But the whole system is giving this dysfunctional result."

On Andrea Sloan’s Facebook page there is a picture that tells of “Three Simple Rules.” The text reads, “If you don’t go after what you want in life, you will never have it. If you don’t ask, the answer will always be No. If you don’t step forward, you’ll always be in the same place.”

Those three rules got rid of my pimples but all we can do is pray for Andrea Sloan. She needs it right now.

royexum@aol.com


Roy Moore Has Not Upheld The Constitution

Regardless of whether Judge Roy Moore was involved in the sexual assault of minors 40 years ago or not, there is a larger problem with Roy Exum's assertion in today’s Chattanoogan that he would vote for the former judge if he could. This, in a nutshell, represents a serious crisis in our country. For some reason Roy Exum seems to think that Judge Roy Moore is the candidate who ... (click for more)

Send Your Opinions To Chattanoogan.com; Include Your Full Name, Address, Phone Number For Verification

We welcome your opinions at Chattanoogan.com. Email to  news@chattanoogan.com . We require your real first and last name and contact information. This includes your home address and phone number. We do not post the contact information, but need it for verification. There is no word limit, but if your article is too long you may lose your reader. Please focus more ... (click for more)

School Board Says It Would Not Sell School Buildings To Signal Mountain

The County School Board on Thursday night passed a resolution saying it would not sell three schools at Signal Mountain if it chooses to break away and form its own school district. Attorney Scott Bennett said the schools would still be needed and be operated for students on Waldens Ridge outside of the town of Signal Mountain. The schools are Signal Mountain Middle/High, Nolan ... (click for more)

Lookout Mountain, Ga. Residents Debate Chicken Issue; Town Calling In Highway Patrol On Speeders

Debate about whether to allow residents of Lookout Mountain, Ga., to keep chickens, took place at a public meeting Thursday afternoon prior to the November city council meeting. Most of the residents who spoke in favor of allowing the animals already keep them despite the town’s ordinance from 1988 prohibiting the practice unless the property is at least five acres.   ... (click for more)

Chattanooga Gets First Win For Coach Lamont Paris

Lamont Paris came into the post-game interview room at McKenzie Arena Thursday night with a smile on his face and he had to feel good after getting his first win as the head coach of the Chattanooga Mocs basketball team. We all know that the Mocs are the youngest team in the NCAA this fall and they had lost their first two games on the road, including an embarrassing 89-47 loss ... (click for more)

Bradley Central Opens With 49-38 Win Vs. William Blount

Bradley Central’s Bearettes opened their high school basketball season Thursday night with a 49-38 victory over William Blount in Maryville, Tennessee. Senior Rhyne Howard, a Miss Basketball finalist last season, led the Bearettes with 20 points and Kimia Carter added 12. Lexi Campos paced William Blount with 11 points. Bradley’s proud defense forced 23 turnovers, ... (click for more)